In addition, 17.90% (n = 63) SLCO1B1 (rs4149056, 521TC), 9.09% (n = 32) SLCO1B1 (rs4149056, 521CC) existed in these patients (Fig. 1b), and patients with these genotypes had a medium and high risk of myopathy and rhabdomyolysis, respectively [27]. This evidence concerns the gene SLCO1B1 and myopathy.